BUSINESS BRIEF

This is a pharmaceutical manufacturing company based in nalagarh, himachal pradesh. it was started in 1999 and formally incorporated in 2005. the company makes medicines like tablets, capsules, injections, syrups, ointments, and powders across 10+ therapeutic categories such as antibiotics, diabetes, cardiovascular, dermatology, and more.

the company has revenues of ₹30 crores in fy2024, growing steadily from ₹20 cr in fy2022. it maintains a healthy ebitda margin of 29%, which means the business is profitable and well-run. it employs a full team with modern, automated manufacturing lines.

it is who-gmp and iso 9001 certified these are internationally recognized quality standards that allow the company to export medicines globally without major barriers.

60% of revenue comes from domestic india through a pan-india distribution network. the remaining 40% comes from exports to countries like the philippines, georgia, uzbekistan, myanmar, yemen, afghanistan, and several african nations over 40 markets in total.

PROPOSAL
🏭
Industry
Industrial Manufacturing
🏗️
Sub Industry
Pharmaceutical Manufacturing
💼
Nature of Business
B2B
📈
Reason for sell-off
Promoter seeking strategic investor/partner for business expansion and growth capital. 51% controlling stake being offered for dilution to fund operational scaling and penetration into new industry
📍
Location
Himachal Pradesh, India
📊
Open For Dilution
Yes – 50% stake available at ₹15 Cr; 100% acquisition at ₹24 Cr
💰
Deal Size
₹ 24 Crore
🏢
Sector
Healthcare & Pharmaceuticals
🧭
Region
North India
👤
Top Customer
🔒 Confidential
✔️
Justification
Land ₹2.5 Cr + Building ₹9 Cr + Machinery ₹7 Cr + Brand & Intangibles ₹5.5 Cr = ₹24 Cr total asset-backed valuation
FINANCIAL INFORMATION
2022 (in INR Cr) 2023 (in INR Cr) 2024 (in INR Cr)
Sales 20 25 30
EBITDA
PAT
BUSINESS DOCUMENTS